Rise Advisors’s ASP Isotopes ASPI Stock Holding History

Rise Advisors’s Portfolio ASPI Stock Details ASPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-193	Closed	-$1.86K	–	206
2025 Q3	$1.86K	Hold	193	–	–	﹤0.01%	1197
2025 Q2	$1.42K	Buy	193 +74	+62%	+$496	﹤0.01%	1232
2025 Q1	$558	Buy	+119	New	+$594	﹤0.01%	1356

Other funds holding ASPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

RIM

Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rise Advisors's ASPI Position: Q4 2025 in Review

Rise Advisors sold out of ASP Isotopes (ASPI) in Q4 2025, closing a stake of 193 shares — an estimated $1.86K sold.

Rise Advisors first reported a position in ASPI in Q1 2025 and held it in 3 quarters. The position peaked at $1.86K in Q3 2025. 173 funds tracked by Wall St. Rank hold ASPI as of Q4 2025.

Rise Advisors reported no remaining ASP Isotopes position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 193 ASP Isotopes shares in Q4 2025, an estimated $1.86K.
Rise Advisors first reported a position in ASP Isotopes in Q1 2025 and held it in 3 quarters.
Rise Advisors's ASP Isotopes position peaked at $1.86K in Q3 2025.
173 funds tracked by Wall St. Rank held ASP Isotopes as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.